Clinical Trials
4 trialsNCT04509596 2025-04-01
DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer
Dizal Pharmaceuticals
Phase 1 Completed
NCT04483505 2023-12-28
ROGABREAST
Fundacion CRIS de Investigación para Vencer el Cáncer
Phase 1 Completed
NCT05301530 2022-03-29
Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Phase 1 Completed
NCT01876251 2019-03-15
A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer
Pfizer
Phase 1 Terminated